Learn More
Selleck Chemical LLC Acalabrutinib

Supplier: Selleck Chemical LLC S8116100MG
Acalabrutinib (ACP-196) is a selective second-generation Bruton s tyrosine kinase (BTK) inhibitor with an IC50 of 3 nM which prevents the activation of the B-cell antigen receptor (BCR) signaling pathway ACP-196 has improved target specificity with 323- 94- 19- and 9-fold selectivity over the other TEC kinase family members (ITK TXK BMX and TEC respectively) and no activity against EGFR
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.